{"gene":"PHC2","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2005,"finding":"Phc2 (mouse polyhomeotic homologue 2) is a constituent of class II PcG complexes and represses Hox cluster genes through direct binding to the Hox locus. Phc2-deficient mice display posterior axial skeleton transformations and premature senescence of MEFs with derepression of Hox and Cdkn2a genes. Coimmunoprecipitation from embryonic extracts confirmed interaction of Phc2 with Phc1 and Rnf110 products within class II PcG complexes, and ChIP with anti-Phc2 antibodies demonstrated direct chromatin association at Hox loci. Genetic synergy between Phc2, Phc1, and Rnf110 mutations reveals functional overlap and strict dose-dependent requirements for A-P specification.","method":"Knockout mouse phenotyping, coimmunoprecipitation from embryonic extracts, chromatin immunoprecipitation (ChIP), genetic epistasis (double/triple mutant analysis)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (KO phenotype, Co-IP, ChIP, genetic epistasis) in a single foundational study, >100 citations","pmids":["16024804"],"is_preprint":false},{"year":2002,"finding":"The mouse Edr2/Phc2 gene produces two transcript isoforms encoding 90-kDa and 36-kDa polypeptides; the 36-kDa form (lacking the N-terminal region) localizes to nuclei and colocalizes with the PcG protein Mel18, indicating it can participate in multimeric PcG complexes despite being a truncated isoform.","method":"cDNA/genomic analysis, immunostaining of HA-tagged protein in mammalian cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, immunostaining colocalization without functional rescue or interaction confirmation by Co-IP","pmids":["12034499"],"is_preprint":false},{"year":2002,"finding":"Human PRC1-like complex (hPRC-H) purified from HeLa cells contains HPH2 (PHC2 human orthologue) along with other core PcG proteins (Ring1, BMI1, HPH1) and retains the Polycomb repressive function of blocking nucleosomal array remodeling, establishing HPH2 as a component of functionally conserved PRC1.","method":"Biochemical purification of hPRC-H from HeLa cells, functional nucleosome remodeling assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1/2 — reconstituted complex purification with functional assay; >300 citations","pmids":["12167701"],"is_preprint":false},{"year":2004,"finding":"HPH2 (PHC2) is a subunit of the hPRC1L E3 ubiquitin ligase complex that monoubiquitinates nucleosomal histone H2A at lysine 119, linking PHC2 to the H2AK119ub Polycomb silencing mechanism.","method":"Biochemical purification, in vitro ubiquitination assay with nucleosomal substrate, RNAi knockdown of Ring2 in HeLa cells, ChIP in Drosophila","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstituted enzymatic activity in vitro with mutagenesis controls and ChIP validation; >1000 citations","pmids":["15386022"],"is_preprint":false},{"year":1997,"finding":"HPH1 (a human PHC paralogue) coimmunoprecipitates with RING1, the human Pc homologue, and BMI1 and colocalizes with them in nuclear PcG domains; RING1 functions as a transcriptional repressor when tethered to a reporter gene, establishing the composition and repressive activity of the human PcG protein complex containing PHC-family proteins.","method":"Yeast two-hybrid screen, coimmunoprecipitation, immunofluorescence colocalization, reporter gene repression assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP and reporter assay, but focuses primarily on HPH1 (PHC1); PHC2 implicated as family member in the same complex","pmids":["9199346"],"is_preprint":false},{"year":2010,"finding":"SIAH-1 (an E3 ubiquitin ligase) directly associates with HPH2 (PHC2) both in vitro and in vivo; the cysteine-rich RING domain of SIAH-1 and the PxVxAxP motif of HPH2 are essential for this interaction. SIAH-1 facilitates ubiquitination and proteasomal degradation of HPH2, identifying SIAH-1 as a direct E3 ligase that controls PHC2 protein stability.","method":"In vitro pull-down, coimmunoprecipitation, colocalization in nuclei, ubiquitination assay, proteasome inhibitor treatment, SIAH-1 E3-dead mutant analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pull-down plus in vivo Co-IP, functional ubiquitination assay with catalytic mutant, single lab","pmids":["20471960"],"is_preprint":false},{"year":2012,"finding":"PHC proteins (including PHC2) are canonical subunits of CBX/PHC/SCM-containing PRC1 complexes. Six distinct PRC1 sub-complexes were defined; RYBP/YAF2-containing PRC1 complexes exclude PHC subunits and show enhanced RING1B H2AK119ub1 activity relative to CBX/PHC-containing complexes, placing PHC2 in complexes with distinct chromatin compaction versus ubiquitination activities.","method":"Comprehensive proteomic affinity purification, ChIP-seq, RNAi knockdown in ESCs, biochemical reconstitution of ubiquitination activity","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1/2 — systematic proteomics, biochemical reconstitution, and genomic profiling; >600 citations","pmids":["22325352"],"is_preprint":false},{"year":2013,"finding":"Phc2 is expressed in helper T (Th) cells and is down-regulated upon antigen-specific activation. Ectopic expression of Phc2 inhibits Th cell proliferation and IL-2 secretion upon stimulation, establishing Phc2 as a negative regulator of Th cell activation.","method":"RT-PCR expression analysis, ectopic overexpression in Th cells, proliferation and cytokine secretion assays upon antigen-specific stimulation","journal":"In vitro cellular & developmental biology. Animal","confidence":"Low","confidence_rationale":"Tier 3 — single lab, overexpression phenotype without pathway placement or molecular target identified","pmids":["23605804"],"is_preprint":false},{"year":2019,"finding":"Genetic ablation of Phc2 in mice causes severe defects in HSPC mobilization from bone marrow due to derepression of Vcam1 in bone marrow stromal cells (BMSCs), leading to systemic immunodeficiency. Phc2-dependent Vcam1 repression is mediated by epigenetic regulation of H3K27me3 and H2AK119ub at the Vcam1 locus. Pharmacological inhibition of VCAM-1 reverses the mobilization defect in Phc2-deficient mice, demonstrating a cell-extrinsic (niche) role for Phc2.","method":"Conditional/global knockout mice, flow cytometry for HSPC trafficking, ChIP for H3K27me3 and H2AK119ub at Vcam1, pharmacological rescue with VCAM-1 inhibitor","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — KO with specific cellular phenotype, ChIP mechanistic validation, and pharmacological rescue; multiple orthogonal methods","pmids":["31375680"],"is_preprint":false},{"year":2024,"finding":"CBX7C, a splicing isoform of CBX7 expressed in mESCs, preferentially interacts with PHC2 to facilitate PRC1 assembly on chromatin. At low levels, the CBX7C·PHC2 interaction promotes formation of dynamic, high-mobility Polycomb bodies; at high doses, the two factors together form large, low-mobility, chromatin-free aggregates. Knockdown of CBX7C abolishes mESC differentiation to embryoid bodies, and the interaction modulates PRC1 phase separation properties.","method":"Co-IP, CRISPR knockdown, fluorescence live-cell imaging (FRAP/mobility analysis), mESC differentiation assay, chromatin fractionation","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP, live imaging with mobility quantification, and functional KD phenotype; single lab","pmids":["38600974"],"is_preprint":false}],"current_model":"PHC2 (polyhomeotic homologue 2) is a core subunit of Polycomb Repressive Complex 1 (PRC1) that represses Hox cluster genes and other developmental targets through direct chromatin association, contributing to H2AK119 monoubiquitination and H3K27me3-dependent epigenetic silencing; its stability is regulated by SIAH-1-mediated ubiquitin-proteasome degradation, it interacts with CBX7C to modulate PRC1 assembly and phase separation into Polycomb bodies, and in vivo it controls HSPC mobilization by repressing Vcam1 in bone marrow stromal cells and negatively regulates helper T cell activation."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing the composition of human PcG complexes answered whether Drosophila Polyhomeotic-like proteins form conserved repressive assemblies in mammals, revealing that PHC-family proteins co-reside with RING1, BMI1, and Pc homologues in nuclear Polycomb domains.","evidence":"Yeast two-hybrid, co-IP, immunofluorescence, and reporter repression assay in human cells (focused on PHC1/HPH1 as representative family member)","pmids":["9199346"],"confidence":"Medium","gaps":["Study focused on HPH1; direct biochemical evidence for PHC2 within the same complex was not provided here","Repressive mechanism (compaction vs. enzymatic) not resolved"]},{"year":2002,"claim":"Biochemical purification of hPRC-H from HeLa cells confirmed that PHC2 (HPH2) is a bona fide subunit of a functionally conserved PRC1 complex that blocks SWI/SNF-mediated nucleosome remodeling, establishing its direct role in chromatin-level repression.","evidence":"Affinity purification of endogenous hPRC-H, functional nucleosome remodeling inhibition assay","pmids":["12167701"],"confidence":"High","gaps":["The enzymatic activity responsible for silencing (ubiquitination) was not yet identified","Whether PHC2 contributes structurally or catalytically to the remodeling block was unknown"]},{"year":2004,"claim":"Demonstrating that the PRC1 complex containing PHC2 monoubiquitinates H2A at K119 resolved the key catalytic output of canonical PRC1 and linked PHC2 to the histone-modification arm of Polycomb silencing.","evidence":"In vitro ubiquitination of nucleosomal H2A, RNAi of Ring2 in HeLa cells, ChIP in Drosophila","pmids":["15386022"],"confidence":"High","gaps":["Whether PHC2 is required for the ubiquitination activity per se or serves a scaffolding/targeting role was not distinguished","In vivo phenotypic consequences of PHC2 loss not yet tested"]},{"year":2005,"claim":"Genetic ablation of Phc2 in mice revealed its non-redundant requirement for Hox gene repression and anterior-posterior patterning, establishing the first in vivo loss-of-function phenotype and demonstrating dose-sensitive genetic synergy with Phc1 and Rnf110.","evidence":"Phc2-knockout mice, ChIP at Hox loci with anti-Phc2 antibody, co-IP from embryonic extracts, double/triple mutant epistasis","pmids":["16024804"],"confidence":"High","gaps":["Cell-type-specific contributions of Phc2 versus Phc1 were not resolved","Non-Hox target genes were not systematically identified"]},{"year":2010,"claim":"Identification of SIAH-1 as the E3 ligase that ubiquitinates PHC2 for proteasomal degradation resolved how PHC2 protein levels are post-translationally controlled, introducing a regulatory layer upstream of PRC1 assembly.","evidence":"In vitro pull-down, co-IP, ubiquitination assay with SIAH-1 catalytic mutant, proteasome inhibitor rescue","pmids":["20471960"],"confidence":"Medium","gaps":["Physiological signals that trigger SIAH-1-mediated PHC2 turnover are unknown","Whether SIAH-1 targets other PRC1 subunits was not tested","Single-lab finding without independent replication"]},{"year":2012,"claim":"Systematic proteomic dissection of six PRC1 sub-complexes placed PHC2 exclusively within canonical CBX/PHC-containing PRC1, distinct from RYBP/YAF2-containing variant PRC1 that has enhanced H2AK119ub1 activity, clarifying that PHC2-containing complexes preferentially mediate chromatin compaction.","evidence":"Affinity purification-mass spectrometry, ChIP-seq, RNAi in ESCs, reconstituted ubiquitination assay","pmids":["22325352"],"confidence":"High","gaps":["The structural basis for mutual exclusivity of PHC and RYBP in PRC1 was not determined","Genome-wide target specificity of PHC2-containing versus variant PRC1 was not fully resolved"]},{"year":2019,"claim":"Demonstrating that Phc2 represses Vcam1 in bone marrow stromal cells via H3K27me3/H2AK119ub and that its loss causes HSPC mobilization failure and immunodeficiency established a cell-extrinsic niche function for Phc2 beyond developmental Hox regulation.","evidence":"Conditional/global Phc2-knockout mice, flow cytometry, ChIP for H3K27me3 and H2AK119ub at Vcam1, pharmacological VCAM-1 inhibitor rescue","pmids":["31375680"],"confidence":"High","gaps":["Whether other PRC1 target genes in BMSCs contribute to the immunodeficiency phenotype was not exhaustively tested","Human relevance of the VCAM-1-dependent niche defect is unconfirmed"]},{"year":2024,"claim":"Showing that the CBX7C splice isoform preferentially interacts with PHC2 to modulate PRC1 phase separation into Polycomb bodies resolved how isoform-specific interactions tune the biophysical properties and chromatin occupancy of canonical PRC1.","evidence":"Co-IP, FRAP/live-cell imaging, CRISPR knockdown, mESC differentiation assay, chromatin fractionation","pmids":["38600974"],"confidence":"Medium","gaps":["Whether CBX7C–PHC2 phase separation is relevant outside mESCs is untested","Structural determinants of preferential CBX7C–PHC2 interaction are unknown","Single-lab observation"]},{"year":null,"claim":"The structural basis for PHC2's scaffolding role within canonical PRC1, the full repertoire of PHC2-specific versus PHC1/PHC3-redundant genomic targets, and the signals controlling SIAH-1-mediated PHC2 turnover in physiological contexts remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of PHC2 in the context of PRC1","Genome-wide target specificity of PHC2 versus other PHC paralogues not systematically mapped","Upstream signals regulating SIAH-1-dependent PHC2 degradation unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,2,3,6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,4,5]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,3,8]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,3,6,8]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,8]}],"complexes":["PRC1 (canonical CBX/PHC-containing Polycomb Repressive Complex 1)"],"partners":["RING1","BMI1","PHC1","RNF2","CBX7","SIAH1","MEL18"],"other_free_text":[]},"mechanistic_narrative":"PHC2 is a core subunit of canonical Polycomb Repressive Complex 1 (PRC1) that mediates transcriptional silencing of developmental target genes, including Hox cluster loci and Vcam1, through direct chromatin association and promotion of H2AK119 monoubiquitination and H3K27me3-dependent epigenetic marks [PMID:16024804, PMID:15386022, PMID:31375680]. Within the PRC1 family, PHC2 resides specifically in CBX/PHC/SCM-containing canonical complexes that are functionally distinct from RYBP/YAF2-containing variant PRC1, and its interaction with the CBX7C splice isoform modulates PRC1 phase separation into Polycomb bodies and chromatin compaction [PMID:22325352, PMID:38600974]. PHC2 protein stability is regulated by SIAH-1-mediated ubiquitination and proteasomal degradation through a PxVxAxP degron motif [PMID:20471960]. In vivo, Phc2 loss causes posterior homeotic transformations, premature senescence, defective hematopoietic stem cell mobilization from bone marrow stroma, and systemic immunodeficiency [PMID:16024804, PMID:31375680]."},"prefetch_data":{"uniprot":{"accession":"Q8IXK0","full_name":"Polyhomeotic-like protein 2","aliases":["Early development regulatory protein 2"],"length_aa":858,"mass_kda":90.7,"function":"Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8IXK0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PHC2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PHC2","total_profiled":1310},"omim":[{"mim_id":"620493","title":"STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 7; SAMD7","url":"https://www.omim.org/entry/620493"},{"mim_id":"616396","title":"SCM POLYCOMB GROUP PROTEIN HOMOLOG 1; SCMH1","url":"https://www.omim.org/entry/616396"},{"mim_id":"602979","title":"POLYHOMEOTIC HOMOLOG 2; PHC2","url":"https://www.omim.org/entry/602979"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PHC2"},"hgnc":{"alias_symbol":["HPH2"],"prev_symbol":["EDR2"]},"alphafold":{"accession":"Q8IXK0","domains":[{"cath_id":"-","chopping":"640-672","consensus_level":"high","plddt":87.6661,"start":640,"end":672},{"cath_id":"1.10.150.50","chopping":"792-858","consensus_level":"high","plddt":93.819,"start":792,"end":858}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IXK0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IXK0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IXK0-F1-predicted_aligned_error_v6.png","plddt_mean":50.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PHC2","jax_strain_url":"https://www.jax.org/strain/search?query=PHC2"},"sequence":{"accession":"Q8IXK0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IXK0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IXK0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IXK0"}},"corpus_meta":[{"pmid":"16024804","id":"PMC_16024804","title":"Mammalian polyhomeotic homologues Phc2 and Phc1 act in synergy to mediate polycomb repression of Hox genes.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16024804","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16212604","id":"PMC_16212604","title":"Regulation of plant defense responses in Arabidopsis by EDR2, a PH and START domain-containing protein.","date":"2005","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16212604","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17612410","id":"PMC_17612410","title":"EDR2 negatively regulates salicylic acid-based defenses and cell death during powdery mildew infections of Arabidopsis thaliana.","date":"2007","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/17612410","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21530897","id":"PMC_21530897","title":"Suppression of edr2-mediated powdery mildew resistance, cell death and ethylene-induced senescence by mutations in ALD1 in Arabidopsis.","date":"2011","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/21530897","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31375680","id":"PMC_31375680","title":"Phc2 controls hematopoietic stem and progenitor cell mobilization from bone marrow by repressing Vcam1 expression.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31375680","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21097665","id":"PMC_21097665","title":"Hph1 and Hph2 are novel components of the Sec63/Sec62 posttranslational translocation complex that aid in vacuolar proton ATPase biogenesis.","date":"2010","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/21097665","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12034499","id":"PMC_12034499","title":"The mouse Edr2 (Mph2) gene has two forms of mRNA encoding 90- and 36-kDa polypeptides.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12034499","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20471960","id":"PMC_20471960","title":"SIAH-1 interacts with mammalian polyhomeotic homologues HPH2 and affects its stability via the ubiquitin-proteasome pathway.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20471960","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23605804","id":"PMC_23605804","title":"Expression pattern and functional role of Phc2 during activation of helper T cells after antigenic stimulation.","date":"2013","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/23605804","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9060407","id":"PMC_9060407","title":"Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse.","date":"1997","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9060407","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38600974","id":"PMC_38600974","title":"CBX7C⋅PHC2 interaction facilitates PRC1 assembly and modulates its phase separation properties.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38600974","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8190122","id":"PMC_8190122","title":"Regulation of polyunsaturated fat induced postprandial hypercholesterolemia by a novel gene Phc-2.","date":"1994","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8190122","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15386022","id":"PMC_15386022","title":"Role of histone H2A ubiquitination in Polycomb silencing.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15386022","citation_count":1377,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22325352","id":"PMC_22325352","title":"PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22325352","citation_count":698,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20850016","id":"PMC_20850016","title":"Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20850016","citation_count":639,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12167701","id":"PMC_12167701","title":"The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12167701","citation_count":319,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25281560","id":"PMC_25281560","title":"Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25281560","citation_count":215,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21653829","id":"PMC_21653829","title":"Protein interactome reveals converging molecular pathways among autism disorders.","date":"2011","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21653829","citation_count":180,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9199346","id":"PMC_9199346","title":"RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9199346","citation_count":165,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17332741","id":"PMC_17332741","title":"Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17332741","citation_count":160,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6970,"output_tokens":1680,"usd":0.023055},"stage2":{"model":"claude-opus-4-6","input_tokens":4918,"output_tokens":1843,"usd":0.105997},"total_usd":0.322781,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":18678,"output_tokens":2800,"usd":0.049017},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6350,"output_tokens":2589,"usd":0.144712}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Phc2 functions as a constituent of class II PcG (PRC1) complexes and mediates transcriptional repression of Hox cluster genes; co-immunoprecipitation from embryonic extracts confirmed physical interaction of Phc2 with Phc1 and Rnf110, and chromatin immunoprecipitation showed direct binding of Phc2 to the Hox locus. Genetic epistasis (synergistic posterior transformations in Phc2/Phc1 and Phc2/Rnf110 double mutants) established that Hox repression requires cooperation among these PRC1 components.\",\n      \"method\": \"Co-immunoprecipitation from embryonic extracts, chromatin immunoprecipitation with anti-Phc2 antibodies, genetic epistasis in knockout mice\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ChIP, and genetic epistasis across multiple mutant combinations, replicated in vivo\",\n      \"pmids\": [\"16024804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The mouse Phc2 (Edr2) gene encodes two isoforms (90 kDa and 36 kDa); the 36-kDa truncated form co-localizes with the PcG protein Mel18 in nuclei, indicating it retains the capacity to assemble into PcG multimeric complexes.\",\n      \"method\": \"Immunostaining of mammalian cells expressing HA-tagged 36-kDa isoform, co-localization with Mel18\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab co-localization experiment without functional follow-up\",\n      \"pmids\": [\"12034499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SIAH-1 (an E3 ubiquitin ligase) directly binds PHC2 (HPH2) through its cysteine-rich region interacting with the PxVxAxP motif of HPH2, and promotes ubiquitination and proteasomal degradation of PHC2; SIAH-1 mutants lacking E3 ligase activity or HPH2-binding capacity failed to degrade HPH2, establishing SIAH-1 as the direct E3 ligase for PHC2.\",\n      \"method\": \"In vitro binding assay, co-immunoprecipitation in vivo, ubiquitination assay, domain mutagenesis, proteasome inhibitor experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro and in vivo binding confirmed, mutagenesis of both interacting domains, ubiquitination assay with catalytic mutant controls\",\n      \"pmids\": [\"20471960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ectopic expression of Phc2 in helper T cells inhibits T cell proliferation and IL-2 secretion upon antigen-specific activation, establishing Phc2 as a negative regulator of helper T cell activation.\",\n      \"method\": \"Ectopic overexpression of Phc2 in Th cells, proliferation assay, IL-2 secretion measurement\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single overexpression study with cellular phenotype but no molecular pathway placement\",\n      \"pmids\": [\"23605804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Phc2 controls hematopoietic stem and progenitor cell (HSPC) mobilization from bone marrow by repressing Vcam1 expression in bone marrow stromal cells via epigenetic regulation of H3K27me3 and H2AK119ub marks; genetic ablation of Phc2 causes derepression of Vcam1, impaired HSPC mobilization, and systemic immunodeficiency, all reversed by pharmacological inhibition of VCAM-1.\",\n      \"method\": \"Phc2 knockout mice, chromatin immunoprecipitation for H3K27me3/H2AK119ub, pharmacological VCAM-1 blockade rescue experiment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, ChIP for histone marks at target locus, pharmacological rescue confirming pathway\",\n      \"pmids\": [\"31375680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX7C preferentially interacts with PHC2 to facilitate PRC1 complex assembly on chromatin in mouse embryonic stem cells; at low concentrations the CBX7C·PHC2 interaction drives formation of mobile, functional Polycomb bodies, whereas high concentrations produce large, low-mobility chromatin-free aggregates, revealing that PHC2 modulates PRC1 phase separation properties.\",\n      \"method\": \"Co-immunoprecipitation, knockdown of CBX7C/Phc2, live-cell imaging of Polycomb bodies (FRAP), mESC differentiation assay\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, live-cell FRAP, and functional differentiation assay in a single study\",\n      \"pmids\": [\"38600974\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PHC2 is a subunit of Polycomb Repressive Complex 1 (PRC1) that physically associates with other PRC1 components (PHC1, RNF110/MEL18, CBX7) to repress Hox genes and other developmental loci via H3K27me3 and H2AK119ub; its stability is regulated by the E3 ligase SIAH-1 through ubiquitin-proteasome degradation, and it exerts cell-extrinsic epigenetic control of VCAM-1 in bone marrow stromal cells to govern hematopoietic stem and progenitor cell mobilization, while also modulating PRC1 phase separation properties through its interaction with CBX7C.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Phc2 (mouse polyhomeotic homologue 2) is a constituent of class II PcG complexes and represses Hox cluster genes through direct binding to the Hox locus. Phc2-deficient mice display posterior axial skeleton transformations and premature senescence of MEFs with derepression of Hox and Cdkn2a genes. Coimmunoprecipitation from embryonic extracts confirmed interaction of Phc2 with Phc1 and Rnf110 products within class II PcG complexes, and ChIP with anti-Phc2 antibodies demonstrated direct chromatin association at Hox loci. Genetic synergy between Phc2, Phc1, and Rnf110 mutations reveals functional overlap and strict dose-dependent requirements for A-P specification.\",\n      \"method\": \"Knockout mouse phenotyping, coimmunoprecipitation from embryonic extracts, chromatin immunoprecipitation (ChIP), genetic epistasis (double/triple mutant analysis)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO phenotype, Co-IP, ChIP, genetic epistasis) in a single foundational study, >100 citations\",\n      \"pmids\": [\"16024804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The mouse Edr2/Phc2 gene produces two transcript isoforms encoding 90-kDa and 36-kDa polypeptides; the 36-kDa form (lacking the N-terminal region) localizes to nuclei and colocalizes with the PcG protein Mel18, indicating it can participate in multimeric PcG complexes despite being a truncated isoform.\",\n      \"method\": \"cDNA/genomic analysis, immunostaining of HA-tagged protein in mammalian cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, immunostaining colocalization without functional rescue or interaction confirmation by Co-IP\",\n      \"pmids\": [\"12034499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human PRC1-like complex (hPRC-H) purified from HeLa cells contains HPH2 (PHC2 human orthologue) along with other core PcG proteins (Ring1, BMI1, HPH1) and retains the Polycomb repressive function of blocking nucleosomal array remodeling, establishing HPH2 as a component of functionally conserved PRC1.\",\n      \"method\": \"Biochemical purification of hPRC-H from HeLa cells, functional nucleosome remodeling assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — reconstituted complex purification with functional assay; >300 citations\",\n      \"pmids\": [\"12167701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HPH2 (PHC2) is a subunit of the hPRC1L E3 ubiquitin ligase complex that monoubiquitinates nucleosomal histone H2A at lysine 119, linking PHC2 to the H2AK119ub Polycomb silencing mechanism.\",\n      \"method\": \"Biochemical purification, in vitro ubiquitination assay with nucleosomal substrate, RNAi knockdown of Ring2 in HeLa cells, ChIP in Drosophila\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity in vitro with mutagenesis controls and ChIP validation; >1000 citations\",\n      \"pmids\": [\"15386022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HPH1 (a human PHC paralogue) coimmunoprecipitates with RING1, the human Pc homologue, and BMI1 and colocalizes with them in nuclear PcG domains; RING1 functions as a transcriptional repressor when tethered to a reporter gene, establishing the composition and repressive activity of the human PcG protein complex containing PHC-family proteins.\",\n      \"method\": \"Yeast two-hybrid screen, coimmunoprecipitation, immunofluorescence colocalization, reporter gene repression assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and reporter assay, but focuses primarily on HPH1 (PHC1); PHC2 implicated as family member in the same complex\",\n      \"pmids\": [\"9199346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SIAH-1 (an E3 ubiquitin ligase) directly associates with HPH2 (PHC2) both in vitro and in vivo; the cysteine-rich RING domain of SIAH-1 and the PxVxAxP motif of HPH2 are essential for this interaction. SIAH-1 facilitates ubiquitination and proteasomal degradation of HPH2, identifying SIAH-1 as a direct E3 ligase that controls PHC2 protein stability.\",\n      \"method\": \"In vitro pull-down, coimmunoprecipitation, colocalization in nuclei, ubiquitination assay, proteasome inhibitor treatment, SIAH-1 E3-dead mutant analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pull-down plus in vivo Co-IP, functional ubiquitination assay with catalytic mutant, single lab\",\n      \"pmids\": [\"20471960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PHC proteins (including PHC2) are canonical subunits of CBX/PHC/SCM-containing PRC1 complexes. Six distinct PRC1 sub-complexes were defined; RYBP/YAF2-containing PRC1 complexes exclude PHC subunits and show enhanced RING1B H2AK119ub1 activity relative to CBX/PHC-containing complexes, placing PHC2 in complexes with distinct chromatin compaction versus ubiquitination activities.\",\n      \"method\": \"Comprehensive proteomic affinity purification, ChIP-seq, RNAi knockdown in ESCs, biochemical reconstitution of ubiquitination activity\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — systematic proteomics, biochemical reconstitution, and genomic profiling; >600 citations\",\n      \"pmids\": [\"22325352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phc2 is expressed in helper T (Th) cells and is down-regulated upon antigen-specific activation. Ectopic expression of Phc2 inhibits Th cell proliferation and IL-2 secretion upon stimulation, establishing Phc2 as a negative regulator of Th cell activation.\",\n      \"method\": \"RT-PCR expression analysis, ectopic overexpression in Th cells, proliferation and cytokine secretion assays upon antigen-specific stimulation\",\n      \"journal\": \"In vitro cellular & developmental biology. Animal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, overexpression phenotype without pathway placement or molecular target identified\",\n      \"pmids\": [\"23605804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Genetic ablation of Phc2 in mice causes severe defects in HSPC mobilization from bone marrow due to derepression of Vcam1 in bone marrow stromal cells (BMSCs), leading to systemic immunodeficiency. Phc2-dependent Vcam1 repression is mediated by epigenetic regulation of H3K27me3 and H2AK119ub at the Vcam1 locus. Pharmacological inhibition of VCAM-1 reverses the mobilization defect in Phc2-deficient mice, demonstrating a cell-extrinsic (niche) role for Phc2.\",\n      \"method\": \"Conditional/global knockout mice, flow cytometry for HSPC trafficking, ChIP for H3K27me3 and H2AK119ub at Vcam1, pharmacological rescue with VCAM-1 inhibitor\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific cellular phenotype, ChIP mechanistic validation, and pharmacological rescue; multiple orthogonal methods\",\n      \"pmids\": [\"31375680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CBX7C, a splicing isoform of CBX7 expressed in mESCs, preferentially interacts with PHC2 to facilitate PRC1 assembly on chromatin. At low levels, the CBX7C·PHC2 interaction promotes formation of dynamic, high-mobility Polycomb bodies; at high doses, the two factors together form large, low-mobility, chromatin-free aggregates. Knockdown of CBX7C abolishes mESC differentiation to embryoid bodies, and the interaction modulates PRC1 phase separation properties.\",\n      \"method\": \"Co-IP, CRISPR knockdown, fluorescence live-cell imaging (FRAP/mobility analysis), mESC differentiation assay, chromatin fractionation\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, live imaging with mobility quantification, and functional KD phenotype; single lab\",\n      \"pmids\": [\"38600974\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PHC2 (polyhomeotic homologue 2) is a core subunit of Polycomb Repressive Complex 1 (PRC1) that represses Hox cluster genes and other developmental targets through direct chromatin association, contributing to H2AK119 monoubiquitination and H3K27me3-dependent epigenetic silencing; its stability is regulated by SIAH-1-mediated ubiquitin-proteasome degradation, it interacts with CBX7C to modulate PRC1 assembly and phase separation into Polycomb bodies, and in vivo it controls HSPC mobilization by repressing Vcam1 in bone marrow stromal cells and negatively regulates helper T cell activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PHC2 is a core subunit of Polycomb Repressive Complex 1 (PRC1) that mediates transcriptional silencing of developmental genes. PHC2 physically associates with other PRC1 components—PHC1, RNF110/MEL18, and CBX7—and directly binds Hox cluster loci to maintain their repression through H3K27me3 and H2AK119ub histone marks; genetic epistasis in compound mutant mice demonstrates cooperative function among these PRC1 subunits [PMID:16024804, PMID:12034499]. In bone marrow stromal cells, Phc2 epigenetically represses Vcam1, controlling hematopoietic stem and progenitor cell mobilization; loss of Phc2 causes Vcam1 derepression, impaired HSPC egress, and systemic immunodeficiency that is rescued by pharmacological VCAM-1 blockade [PMID:31375680]. PHC2 protein stability is regulated by SIAH-1-mediated ubiquitination and proteasomal degradation [PMID:20471960], and its interaction with the CBX7C isoform modulates PRC1 phase separation behavior, shifting Polycomb bodies between functional mobile condensates and non-functional aggregates in a concentration-dependent manner [PMID:38600974].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that Phc2 encodes PcG-associated isoforms answered the basic question of whether Phc2 products can integrate into Polycomb complexes, showing that even the truncated 36 kDa isoform retains nuclear co-localization with Mel18.\",\n      \"evidence\": \"Immunostaining of HA-tagged 36-kDa isoform in mammalian cells, co-localization with Mel18\",\n      \"pmids\": [\"12034499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No biochemical evidence of direct binding between 36-kDa isoform and Mel18\",\n        \"Functional significance of the two isoforms not determined\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that Phc2 physically occupies Hox loci and genetically cooperates with Phc1 and Rnf110 established it as a bona fide PRC1 subunit required for Hox gene silencing in vivo, resolving whether Phc2 is functionally redundant with Phc1.\",\n      \"evidence\": \"Co-immunoprecipitation from embryonic extracts, ChIP with anti-Phc2, genetic epistasis in single and compound knockout mice\",\n      \"pmids\": [\"16024804\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct versus indirect chromatin recruitment mechanism not resolved\",\n        \"Genome-wide target repertoire beyond Hox loci not mapped\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying SIAH-1 as the E3 ligase that ubiquitinates and degrades PHC2 revealed how PRC1 stoichiometry is post-translationally regulated, answering how PHC2 protein levels are controlled.\",\n      \"evidence\": \"In vitro binding, in vivo Co-IP, ubiquitination assay with catalytic-dead and binding-deficient SIAH-1 mutants, proteasome inhibitor experiments\",\n      \"pmids\": [\"20471960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological signals triggering SIAH-1–mediated PHC2 degradation unknown\",\n        \"Consequences of PHC2 stabilization for PRC1 target gene expression not tested\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking Phc2 to HSPC mobilization via cell-extrinsic epigenetic repression of Vcam1 in bone marrow stroma demonstrated a non-cell-autonomous PRC1 function and explained how Phc2 loss causes systemic immunodeficiency.\",\n      \"evidence\": \"Phc2 knockout mice, ChIP for H3K27me3 and H2AK119ub at Vcam1, pharmacological VCAM-1 blockade rescue\",\n      \"pmids\": [\"31375680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other PRC1 subunits share this stromal regulatory role not addressed\",\n        \"Genome-wide identification of additional Phc2 target genes in stromal cells not performed\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that the CBX7C–PHC2 interaction tunes PRC1 phase separation properties explained how Polycomb body formation is dynamically regulated and why concentration-dependent aggregation can produce non-functional condensates.\",\n      \"evidence\": \"Co-IP, CBX7C/Phc2 knockdown, live-cell FRAP of Polycomb bodies, mESC differentiation assay\",\n      \"pmids\": [\"38600974\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of the CBX7C–PHC2 interaction not resolved\",\n        \"In vivo relevance of concentration-dependent phase transition not tested in animal models\",\n        \"Whether other PHC family members similarly modulate phase separation is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the genome-wide target repertoire of PHC2-containing PRC1 in different cell types, the signals that regulate SIAH-1-mediated PHC2 turnover in vivo, and the structural determinants governing PHC2's role in PRC1 phase separation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide ChIP-seq for PHC2 across multiple cell types\",\n        \"No structural model of PHC2 in complex with PRC1\",\n        \"Physiological regulation of SIAH-1-mediated PHC2 degradation unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 4, 5]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"PRC1\"\n    ],\n    \"partners\": [\n      \"PHC1\",\n      \"RNF110\",\n      \"CBX7\",\n      \"SIAH1\",\n      \"MEL18\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PHC2 is a core subunit of canonical Polycomb Repressive Complex 1 (PRC1) that mediates transcriptional silencing of developmental target genes, including Hox cluster loci and Vcam1, through direct chromatin association and promotion of H2AK119 monoubiquitination and H3K27me3-dependent epigenetic marks [PMID:16024804, PMID:15386022, PMID:31375680]. Within the PRC1 family, PHC2 resides specifically in CBX/PHC/SCM-containing canonical complexes that are functionally distinct from RYBP/YAF2-containing variant PRC1, and its interaction with the CBX7C splice isoform modulates PRC1 phase separation into Polycomb bodies and chromatin compaction [PMID:22325352, PMID:38600974]. PHC2 protein stability is regulated by SIAH-1-mediated ubiquitination and proteasomal degradation through a PxVxAxP degron motif [PMID:20471960]. In vivo, Phc2 loss causes posterior homeotic transformations, premature senescence, defective hematopoietic stem cell mobilization from bone marrow stroma, and systemic immunodeficiency [PMID:16024804, PMID:31375680].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing the composition of human PcG complexes answered whether Drosophila Polyhomeotic-like proteins form conserved repressive assemblies in mammals, revealing that PHC-family proteins co-reside with RING1, BMI1, and Pc homologues in nuclear Polycomb domains.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, immunofluorescence, and reporter repression assay in human cells (focused on PHC1/HPH1 as representative family member)\",\n      \"pmids\": [\"9199346\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Study focused on HPH1; direct biochemical evidence for PHC2 within the same complex was not provided here\", \"Repressive mechanism (compaction vs. enzymatic) not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Biochemical purification of hPRC-H from HeLa cells confirmed that PHC2 (HPH2) is a bona fide subunit of a functionally conserved PRC1 complex that blocks SWI/SNF-mediated nucleosome remodeling, establishing its direct role in chromatin-level repression.\",\n      \"evidence\": \"Affinity purification of endogenous hPRC-H, functional nucleosome remodeling inhibition assay\",\n      \"pmids\": [\"12167701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The enzymatic activity responsible for silencing (ubiquitination) was not yet identified\", \"Whether PHC2 contributes structurally or catalytically to the remodeling block was unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that the PRC1 complex containing PHC2 monoubiquitinates H2A at K119 resolved the key catalytic output of canonical PRC1 and linked PHC2 to the histone-modification arm of Polycomb silencing.\",\n      \"evidence\": \"In vitro ubiquitination of nucleosomal H2A, RNAi of Ring2 in HeLa cells, ChIP in Drosophila\",\n      \"pmids\": [\"15386022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PHC2 is required for the ubiquitination activity per se or serves a scaffolding/targeting role was not distinguished\", \"In vivo phenotypic consequences of PHC2 loss not yet tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic ablation of Phc2 in mice revealed its non-redundant requirement for Hox gene repression and anterior-posterior patterning, establishing the first in vivo loss-of-function phenotype and demonstrating dose-sensitive genetic synergy with Phc1 and Rnf110.\",\n      \"evidence\": \"Phc2-knockout mice, ChIP at Hox loci with anti-Phc2 antibody, co-IP from embryonic extracts, double/triple mutant epistasis\",\n      \"pmids\": [\"16024804\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific contributions of Phc2 versus Phc1 were not resolved\", \"Non-Hox target genes were not systematically identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of SIAH-1 as the E3 ligase that ubiquitinates PHC2 for proteasomal degradation resolved how PHC2 protein levels are post-translationally controlled, introducing a regulatory layer upstream of PRC1 assembly.\",\n      \"evidence\": \"In vitro pull-down, co-IP, ubiquitination assay with SIAH-1 catalytic mutant, proteasome inhibitor rescue\",\n      \"pmids\": [\"20471960\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological signals that trigger SIAH-1-mediated PHC2 turnover are unknown\", \"Whether SIAH-1 targets other PRC1 subunits was not tested\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Systematic proteomic dissection of six PRC1 sub-complexes placed PHC2 exclusively within canonical CBX/PHC-containing PRC1, distinct from RYBP/YAF2-containing variant PRC1 that has enhanced H2AK119ub1 activity, clarifying that PHC2-containing complexes preferentially mediate chromatin compaction.\",\n      \"evidence\": \"Affinity purification-mass spectrometry, ChIP-seq, RNAi in ESCs, reconstituted ubiquitination assay\",\n      \"pmids\": [\"22325352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The structural basis for mutual exclusivity of PHC and RYBP in PRC1 was not determined\", \"Genome-wide target specificity of PHC2-containing versus variant PRC1 was not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that Phc2 represses Vcam1 in bone marrow stromal cells via H3K27me3/H2AK119ub and that its loss causes HSPC mobilization failure and immunodeficiency established a cell-extrinsic niche function for Phc2 beyond developmental Hox regulation.\",\n      \"evidence\": \"Conditional/global Phc2-knockout mice, flow cytometry, ChIP for H3K27me3 and H2AK119ub at Vcam1, pharmacological VCAM-1 inhibitor rescue\",\n      \"pmids\": [\"31375680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other PRC1 target genes in BMSCs contribute to the immunodeficiency phenotype was not exhaustively tested\", \"Human relevance of the VCAM-1-dependent niche defect is unconfirmed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that the CBX7C splice isoform preferentially interacts with PHC2 to modulate PRC1 phase separation into Polycomb bodies resolved how isoform-specific interactions tune the biophysical properties and chromatin occupancy of canonical PRC1.\",\n      \"evidence\": \"Co-IP, FRAP/live-cell imaging, CRISPR knockdown, mESC differentiation assay, chromatin fractionation\",\n      \"pmids\": [\"38600974\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CBX7C–PHC2 phase separation is relevant outside mESCs is untested\", \"Structural determinants of preferential CBX7C–PHC2 interaction are unknown\", \"Single-lab observation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for PHC2's scaffolding role within canonical PRC1, the full repertoire of PHC2-specific versus PHC1/PHC3-redundant genomic targets, and the signals controlling SIAH-1-mediated PHC2 turnover in physiological contexts remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of PHC2 in the context of PRC1\", \"Genome-wide target specificity of PHC2 versus other PHC paralogues not systematically mapped\", \"Upstream signals regulating SIAH-1-dependent PHC2 degradation unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 2, 3, 6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 4, 5]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 3, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3, 6, 8]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"complexes\": [\n      \"PRC1 (canonical CBX/PHC-containing Polycomb Repressive Complex 1)\"\n    ],\n    \"partners\": [\n      \"RING1\",\n      \"BMI1\",\n      \"PHC1\",\n      \"RNF2\",\n      \"CBX7\",\n      \"SIAH1\",\n      \"MEL18\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}